company SOPH - SteadyBase

steadybase-$ company SOPH

account_id none on file

legal_name SOPHiA GENETICS SA

ticker SOPH

cik 1840706

domain sophiagenetics.com

linkedin_company_url https://www.linkedin.com/company/sophiagenetics/

entry_point_account_id none on file

exchange Nasdaq

sector Health Care

irhttps://ir.sophiagenetics.com/

sector index/company/sector/health-care/

calls 4 filings 64 executives 21 family 0

why_nownone on file

calls

And I've been traveling recently as well in Canada, in Montreal, and in New York, and it was pretty fascinating to see how hospitals are moving, if we refer to the Illumina sequencers, you know, beyond Nexic to Novacic.

May 9, 2023 / receipt, needs a key / Yogi, CEO | earnings call 2023-05-09 | transcript a3c89a7d-72ed-46ba-bbf0-1763db9521c6 | chars 22098-22317 | segment 21

A fact which was very much validated during my recent travels with our sales team, spending important face-to-face time with our customers.

Nov 8, 2022 / receipt, needs a key / Yergi Camblong, CEO | earnings call 2022-11-08 | transcript eeed0e7c-73c8-4fdd-aa9e-0047ff62371c | chars 5050-5189 | segment 5

Sales and marketing expenses for the third quarter were $7.9 million compared to $7.7 million in the third quarter of 2021. This moderate increase is primarily related to a continued step up in travel and conference related costs.

Nov 8, 2022 / receipt, needs a key / Ross, CFO | earnings call 2022-11-08 | transcript eeed0e7c-73c8-4fdd-aa9e-0047ff62371c | chars 25796-26026 | segment 26

The increase was primarily due to an increase in headcount-related expenses, commissions and sales-related costs, and higher variable expenses, including marketing and travel-related expenses as COVID-19 restrictions continue to be lifted.

Nov 10, 2021 / receipt, needs a key / Ross, other | earnings call 2021-11-10 | transcript 008b55c6-76d8-48f3-8378-b27799561f69 | chars 22387-22626 | segment 22

filings

Jurgi Camblong | Chief Executive Officer and Director | 47